FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001718453> ?p ?o ?g. }

• W2001718453 endingPage "271" @default.
• W2001718453 startingPage "270" @default.
• W2001718453 abstract "Annals of the New York Academy of SciencesVolume 861, Issue 1 p. 270-271 The Selective 5-HT1B Receptor Inverse Agonist SB-224289, Potently Blocks Terminal 5-HT Autoreceptor Function both in Vitro and in Vivo L. M. GASTER, Corresponding Author L. M. GASTER SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UK Corresponding author: Tel: 44.1279.62.2437; Fax: 44.12790; http://Laramie_Gaster-1@sbphrd.comSearch for more papers by this authorP. HAM, P. HAM SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorG. F. JOINER, G. F. JOINER SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorF. D. KING, F. D. KING SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorK. R. MULHOLLAND, K. R. MULHOLLAND SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorP. A. WYMAN, P. A. WYMAN SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorJ. J. HAGAN, J. J. HAGAN SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorG. W. PRICE, G. W. PRICE SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorC. ROBERTS, C. ROBERTS SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorC. ROUTLEDGE, C. ROUTLEDGE SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorJ. SELKIRK, J. SELKIRK SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorP. D. SLADE, P. D. SLADE SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorD. N. MIDDLEMISS, D. N. MIDDLEMISS SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this author L. M. GASTER, Corresponding Author L. M. GASTER SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UK Corresponding author: Tel: 44.1279.62.2437; Fax: 44.12790; http://Laramie_Gaster-1@sbphrd.comSearch for more papers by this authorP. HAM, P. HAM SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorG. F. JOINER, G. F. JOINER SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorF. D. KING, F. D. KING SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorK. R. MULHOLLAND, K. R. MULHOLLAND SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorP. A. WYMAN, P. A. WYMAN SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorJ. J. HAGAN, J. J. HAGAN SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorG. W. PRICE, G. W. PRICE SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorC. ROBERTS, C. ROBERTS SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorC. ROUTLEDGE, C. ROUTLEDGE SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorJ. SELKIRK, J. SELKIRK SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorP. D. SLADE, P. D. SLADE SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this authorD. N. MIDDLEMISS, D. N. MIDDLEMISS SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, CM19 5AW, UKSearch for more papers by this author First published: 07 February 2006 https://doi.org/10.1111/j.1749-6632.1998.tb10219.xCitations: 11Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume861, Issue1ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICSa December 1998Pages 270-271 RelatedInformation" @default.
• W2001718453 created "2016-06-24" @default.
• W2001718453 creator A5001749587 @default.
• W2001718453 creator A5003948732 @default.
• W2001718453 creator A5005771902 @default.
• W2001718453 creator A5022674193 @default.
• W2001718453 creator A5030371492 @default.
• W2001718453 creator A5031512755 @default.
• W2001718453 creator A5035235333 @default.
• W2001718453 creator A5043951564 @default.
• W2001718453 creator A5044688996 @default.
• W2001718453 creator A5059553552 @default.
• W2001718453 creator A5061793350 @default.
• W2001718453 creator A5070313536 @default.
• W2001718453 creator A5042854922 @default.
• W2001718453 date "1998-12-01" @default.
• W2001718453 modified "2023-09-23" @default.
• W2001718453 title "The Selective 5-HT1B Receptor Inverse Agonist SB-224289, Potently Blocks Terminal 5-HT Autoreceptor Function both in Vitro and in Vivo" @default.
• W2001718453 cites W1983647806 @default.
• W2001718453 cites W2076634042 @default.
• W2001718453 doi "https://doi.org/10.1111/j.1749-6632.1998.tb10219.x" @default.
• W2001718453 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9928285" @default.
• W2001718453 hasPublicationYear "1998" @default.
• W2001718453 type Work @default.
• W2001718453 sameAs 2001718453 @default.
• W2001718453 citedByCount "14" @default.
• W2001718453 countsByYear W20017184532012 @default.
• W2001718453 countsByYear W20017184532013 @default.
• W2001718453 countsByYear W20017184532016 @default.
• W2001718453 countsByYear W20017184532020 @default.
• W2001718453 crossrefType "journal-article" @default.
• W2001718453 hasAuthorship W2001718453A5001749587 @default.
• W2001718453 hasAuthorship W2001718453A5003948732 @default.
• W2001718453 hasAuthorship W2001718453A5005771902 @default.
• W2001718453 hasAuthorship W2001718453A5022674193 @default.
• W2001718453 hasAuthorship W2001718453A5030371492 @default.
• W2001718453 hasAuthorship W2001718453A5031512755 @default.
• W2001718453 hasAuthorship W2001718453A5035235333 @default.
• W2001718453 hasAuthorship W2001718453A5042854922 @default.
• W2001718453 hasAuthorship W2001718453A5043951564 @default.
• W2001718453 hasAuthorship W2001718453A5044688996 @default.
• W2001718453 hasAuthorship W2001718453A5059553552 @default.
• W2001718453 hasAuthorship W2001718453A5061793350 @default.
• W2001718453 hasAuthorship W2001718453A5070313536 @default.
• W2001718453 hasConcept C138885662 @default.
• W2001718453 hasConcept C15708023 @default.
• W2001718453 hasConcept C170493617 @default.
• W2001718453 hasConcept C17744445 @default.
• W2001718453 hasConcept C185592680 @default.
• W2001718453 hasConcept C2778938600 @default.
• W2001718453 hasConcept C55493867 @default.
• W2001718453 hasConcept C8439214 @default.
• W2001718453 hasConceptScore W2001718453C138885662 @default.
• W2001718453 hasConceptScore W2001718453C15708023 @default.
• W2001718453 hasConceptScore W2001718453C170493617 @default.
• W2001718453 hasConceptScore W2001718453C17744445 @default.
• W2001718453 hasConceptScore W2001718453C185592680 @default.
• W2001718453 hasConceptScore W2001718453C2778938600 @default.
• W2001718453 hasConceptScore W2001718453C55493867 @default.
• W2001718453 hasConceptScore W2001718453C8439214 @default.
• W2001718453 hasIssue "1" @default.
• W2001718453 hasLocation W20017184531 @default.
• W2001718453 hasLocation W20017184532 @default.
• W2001718453 hasOpenAccess W2001718453 @default.
• W2001718453 hasPrimaryLocation W20017184531 @default.
• W2001718453 hasRelatedWork W1531601525 @default.
• W2001718453 hasRelatedWork W2319480705 @default.
• W2001718453 hasRelatedWork W2384464875 @default.
• W2001718453 hasRelatedWork W2398689458 @default.
• W2001718453 hasRelatedWork W2606230654 @default.
• W2001718453 hasRelatedWork W2607424097 @default.
• W2001718453 hasRelatedWork W2748952813 @default.
• W2001718453 hasRelatedWork W2899084033 @default.
• W2001718453 hasRelatedWork W2948807893 @default.
• W2001718453 hasRelatedWork W2778153218 @default.
• W2001718453 hasVolume "861" @default.
• W2001718453 isParatext "false" @default.
• W2001718453 isRetracted "false" @default.
• W2001718453 magId "2001718453" @default.
• W2001718453 workType "article" @default.